| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/02/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2023 |
3
| GARDINER SANDRA A. (Acting CFO) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2022 |
4
| Lawler Joseph F. (10% Owner) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Granted 30,425 options to buy
@ $6, valued at
$182.6k
|
|
| 10/04/2022 |
4
| Lin Kenneth (Director) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Granted 30,425 options to buy
@ $6, valued at
$182.6k
|
|
| 10/03/2022 |
4
| Parschauer Karah Herdman (Director) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Granted 30,425 options to buy
@ $6, valued at
$182.6k
|
|
| 10/03/2022 |
4
| Aryeh Jason (Director) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Granted 30,425 options to buy
@ $6, valued at
$182.6k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| ALLEN SIMON (CEO) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Granted 77,457 options to buy
@ $7.02, valued at
$543.7k
|
|
| 09/30/2022 |
4
| English Aron R. (10% Owner) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Granted 1,703,577 shares
@ $2.81, valued at
$4.8M
Granted 30,425 options to buy
@ $6, valued at
$182.6k
Granted 1,703,577 options to buy
@ $4.215, valued at
$7.2M
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
3
| ALLEN SIMON (CEO) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 12/21/2021 |
4
| English Aron R. (10% Owner) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.|
Txns:
| Bought 400 shares
@ $6.5858, valued at
$2.6k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
3
| Parschauer Karah Herdman (Director) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 05/06/2021 |
3
| Aryeh Jason (Director) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 05/06/2021 |
3
| Merchant James R. (CFO) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 05/06/2021 |
3
| Schneeberger Daniel (CEO) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 05/06/2021 |
3
| English Aron R. (10% Owner) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 05/06/2021 |
3
| Kupchyk Areta (Director) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |
| 05/06/2021 |
3
| Lin Kenneth (Director) has filed a Form 3 on Anebulo Pharmaceuticals, Inc. |